158 related articles for article (PubMed ID: 3885960)
21. Antibodies to DNA in patients with systemic lupus erythematosus. Their role in the diagnosis, the follow-up and the pathogenesis of the disease.
Smeenk R; Brinkman K; van den Brink H; Termaat RM; Berden J; Nossent H; Swaak T
Clin Rheumatol; 1990 Mar; 9(1 Suppl 1):100-10. PubMed ID: 2203588
[TBL] [Abstract][Full Text] [Related]
22. Correlation and predictive accuracy of circulating immune complexes with disease activity in patients with systemic lupus erythematosus.
Abrass CK; Nies KM; Louie JS; Border WA; Glassock RJ
Arthritis Rheum; 1980 Mar; 23(3):273-82. PubMed ID: 6987992
[TBL] [Abstract][Full Text] [Related]
23. [Relationship of renal histopathology to immunoglobulin classes and complement fixation of anti-native DNA antibodies and components of immune complexes in patients with systemic lupus erythematosus (author's transl)].
Hashimoto H; Utagawa Y; Yamagata J; Okada T; Shiokawa Y; Suzuki S; Tomiyama T
Ryumachi; 1981 Sep; 21(5):366-74. PubMed ID: 6977194
[No Abstract] [Full Text] [Related]
24. The prognostic and therapeutic implications of DNA:anti-DNA immune complexes in systemic lupus erythematosus (SLE).
Bardana EJ; Harbeck RJ; Hoffman AA; Pirofsky B; Carr RI
Am J Med; 1975 Oct; 59(4):515-22. PubMed ID: 1166858
[TBL] [Abstract][Full Text] [Related]
25. Complement fixing properties of antibodies to double-stranded DNA in systemic lupus erythematosus.
Gharavi AE; Elkon KB; Schifferli JA; Hughes GR
J Clin Lab Immunol; 1981 Nov; 6(3):251-5. PubMed ID: 7338885
[TBL] [Abstract][Full Text] [Related]
26. Significance of antibodies to double-stranded DNA in 30 systemic lupus erythematosus patients.
Golan DT; Gilhar A; Wolf V
Isr J Med Sci; 1979 Jun; 15(6):507-11. PubMed ID: 313389
[TBL] [Abstract][Full Text] [Related]
27. [Determination of anti-native DNA antibodies by immunofluorescence on Crithidia luciliae. Correlation between renal involvement and the presence of high-avidity anti-native DNA antibodies in lupic disease].
Meyer O; Borda-Iriarte O; Haïm T; Ryckewaert A
Presse Med; 1984 Dec; 13(46):2801-5. PubMed ID: 6240645
[TBL] [Abstract][Full Text] [Related]
28. A comparison of three anti-double stranded DNA antibody assays on sera from SLE and other diseases.
Clarke MC; Carr R; Burdash NM; Chen ZY; Ainsworth SK
Diagn Immunol; 1986; 4(6):288-93. PubMed ID: 3545632
[TBL] [Abstract][Full Text] [Related]
29. A new specific assay for the detection of DNA immune complexes: its relevance in SLE.
Klemp P; Meyers OL; Harley EH
Ann Rheum Dis; 1983 Jun; 42(3):317-22. PubMed ID: 6859963
[TBL] [Abstract][Full Text] [Related]
30. [Circulating interferon in patients with systemic lupus erythematosus. A prospective study].
Dudli C; Kaiser V; Aguet M; Joller H; Pichler WI; Grob PJ; Fontana A
Schweiz Med Wochenschr; 1986 Jan; 116(4):104-9. PubMed ID: 2419975
[TBL] [Abstract][Full Text] [Related]
31. Avidity of anti-native DNA antibody and glomerular immune complex localization in lupus nephritis.
Asano Y; Nakamoto Y
Clin Nephrol; 1978 Oct; 10(4):123-9. PubMed ID: 309813
[TBL] [Abstract][Full Text] [Related]
32. Avidity of anti-DNA antibodies in serum and IgG glomerular eluates from patients with systemic lupus erythematosus. Association of high avidity antinative DNA antibody with glomerulonephritis.
Winfield JB; Faiferman I; Koffler D
J Clin Invest; 1977 Jan; 59(1):90-6. PubMed ID: 299748
[TBL] [Abstract][Full Text] [Related]
33. Correlation between the levels of antinuclear antibodies, anti-DNA antibodies, and complement in systemic lupus erythematosus.
Nguyen CP; Cao VV; Fehér J; Gergely P
Acta Med Hung; 1988; 45(2):145-59. PubMed ID: 3266790
[TBL] [Abstract][Full Text] [Related]
34. A longitudinal study of circulating immune complexes, dna antibodies and complement in patients with systemic lupus erythematosus: an analysis of their relationship to disease activity.
Harkiss GD; Hazleman BL; Brown DL
J Clin Lab Immunol; 1979 Nov; 2(4):275-83. PubMed ID: 537024
[TBL] [Abstract][Full Text] [Related]
35. Avidity of antibodies to dsDNA: comparison of IFT on Crithidia luciliae, Farr assay, and PEG assay.
Smeenk R; van der Lelij G; Aarden L
J Immunol; 1982 Jan; 128(1):73-8. PubMed ID: 7033379
[TBL] [Abstract][Full Text] [Related]
36. Histone antibodies in systemic lupus erythematosus. A possible diagnostic tool.
Gioud M; Kaci MA; Monier JC
Arthritis Rheum; 1982 Apr; 25(4):407-13. PubMed ID: 6978717
[TBL] [Abstract][Full Text] [Related]
37. Useful laboratory measurements in the management of systemic lupus erythematosus.
Morrow WJ; Isenberg DA; Todd-Pokropek A; Parry HF; Snaith ML
Q J Med; 1982; 51(202):125-38. PubMed ID: 6981121
[TBL] [Abstract][Full Text] [Related]
38. Measurement of serum DNA binding in chronic active hepatitis and systemic lupus erythematosus using the Farr assay.
Pollard KM; Steele R; Hogg S; Webb J
Rheumatol Int; 1986; 6(3):139-44. PubMed ID: 3529336
[TBL] [Abstract][Full Text] [Related]
39. Disease activity in the nephritis of systemic lupus erythematosus in relation to serum complement concentrations. DNA-binding capacity and precipitating anti-DNA antibody.
Cameron JS; Lessof MH; Ogg CS; Williams BD; Williams DG
Clin Exp Immunol; 1976 Sep; 25(3):418-27. PubMed ID: 1085678
[TBL] [Abstract][Full Text] [Related]
40. Anti-dsDNA antibody subtypes and anti-C1q antibodies: toward a more reliable diagnosis and monitoring of systemic lupus erythematosus and lupus nephritis.
Jaekell HP; Trabandt A; Grobe N; Werle E
Lupus; 2006; 15(6):335-45. PubMed ID: 16830879
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
